Aclarion announces addition of keck medical center of usc as clarity trial site

Usc spine center, part of keck medicine of usc, specializes in treating complex spine conditions with the latest cutting-edge technologies clarity is a randomized clinical trial designed to demonstrate nociscan's ability to improve surgical outcomes for chronic low back pain nociscan aims to become the gold standard in identifying sources of low back pain through mr spectroscopy (mrs) and augmented intelligence (ai) broomfield, colo., may 20, 2025 (globe newswire) -- aclarion, inc., (“aclarion” or the “company”) (nasdaq: acon, aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (ai) algorithms to help physicians identify the location of chronic low back pain, today announced the addition of keck medical center of usc as a clarity (chronic low back pain randomized independent trial study) trial site.
ACON Ratings Summary
ACON Quant Ranking